{"transactions":[{"id":707410,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4147,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Prior to his resignation from the board of directors of the Issuer in connection with the Issuer's 2026 annual meeting of stockholders, Joseph Pearlberg, an employee of Deerfield Management, served as a director of the Issuer. The reported shares of Class A Common Stock and stock options were held by Mr. Pearlberg for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":75.53,"expiration_date":"2035-06-18","underlying":"Class A Common Stock","underlying_shares":4147},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":18,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707409,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":4147,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Prior to the consummation of the transactions contemplated by the Merger Agreement, Cameron Wheeler, a partner in Deerfield Management Company, L.P. (\"Deerfield Management\"), served as a director of the Issuer. The reported shares of Class A Common Stock, RSUs (as defined below) and stock options were held by Dr. Wheeler for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":75.53,"expiration_date":"2035-06-18","underlying":"Class A Common Stock","underlying_shares":4147},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":17,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707408,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3789,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Prior to his resignation from the board of directors of the Issuer in connection with the Issuer's 2026 annual meeting of stockholders, Joseph Pearlberg, an employee of Deerfield Management, served as a director of the Issuer. The reported shares of Class A Common Stock and stock options were held by Mr. Pearlberg for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":80.03,"expiration_date":"2034-06-12","underlying":"Class A Common Stock","underlying_shares":3789},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707407,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3789,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Prior to the consummation of the transactions contemplated by the Merger Agreement, Cameron Wheeler, a partner in Deerfield Management Company, L.P. (\"Deerfield Management\"), served as a director of the Issuer. The reported shares of Class A Common Stock, RSUs (as defined below) and stock options were held by Dr. Wheeler for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":80.03,"expiration_date":"2034-06-12","underlying":"Class A Common Stock","underlying_shares":3789},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707406,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Prior to his resignation from the board of directors of the Issuer in connection with the Issuer's 2026 annual meeting of stockholders, Joseph Pearlberg, an employee of Deerfield Management, served as a director of the Issuer. The reported shares of Class A Common Stock and stock options were held by Mr. Pearlberg for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":44.68,"expiration_date":"2033-06-15","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707405,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":15000,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Prior to the consummation of the transactions contemplated by the Merger Agreement, Cameron Wheeler, a partner in Deerfield Management Company, L.P. (\"Deerfield Management\"), served as a director of the Issuer. The reported shares of Class A Common Stock, RSUs (as defined below) and stock options were held by Dr. Wheeler for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":44.68,"expiration_date":"2033-06-15","underlying":"Class A Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707404,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Prior to his resignation from the board of directors of the Issuer in connection with the Issuer's 2026 annual meeting of stockholders, Joseph Pearlberg, an employee of Deerfield Management, served as a director of the Issuer. The reported shares of Class A Common Stock and stock options were held by Mr. Pearlberg for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":9.36,"expiration_date":"2032-06-16","underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707403,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":20000,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Prior to the consummation of the transactions contemplated by the Merger Agreement, Cameron Wheeler, a partner in Deerfield Management Company, L.P. (\"Deerfield Management\"), served as a director of the Issuer. The reported shares of Class A Common Stock, RSUs (as defined below) and stock options were held by Dr. Wheeler for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":9.36,"expiration_date":"2032-06-16","underlying":"Class A Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707402,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":43000,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Prior to his resignation from the board of directors of the Issuer in connection with the Issuer's 2026 annual meeting of stockholders, Joseph Pearlberg, an employee of Deerfield Management, served as a director of the Issuer. The reported shares of Class A Common Stock and stock options were held by Mr. Pearlberg for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":17,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":43000},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707401,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Stock Option (right to buy)","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":43000,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Pursuant to the Merger Agreement, each option to purchase shares of Class A Common Stock that was outstanding immediately prior to the effective time of the Merger was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to such stock option immediately prior to the effective time of the Merger and (y) the excess, if any, of $124.00 over the applicable exercise price per share under such stock option. The disposition or deemed disposition of such securities by the reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Prior to the consummation of the transactions contemplated by the Merger Agreement, Cameron Wheeler, a partner in Deerfield Management Company, L.P. (\"Deerfield Management\"), served as a director of the Issuer. The reported shares of Class A Common Stock, RSUs (as defined below) and stock options were held by Dr. Wheeler for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"derivative":{"exercise_price":17,"expiration_date":"2031-07-28","underlying":"Class A Common Stock","underlying_shares":43000},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707400,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class B Common Stock","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2717627,"price":124,"value":336985748.0,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the \"Merger Agreement\"), by and among (i) the Issuer, (ii) GlaxoSmithKline LLC (\"Parent\"), (iii) Harmony Row Acquisition Co. (\"Purchaser\") and (iv) solely for purposes of Section 9.14 therein, GSK plc, upon the effective time of the merger contemplated thereby (the \"Merger\") each share of Class A Common Stock and each share of Class B Common Stock beneficially owned by the Reporting Persons was cancelled and converted into the right to receive $124.00, in cash. The disposition or deemed disposition of such securities by the Reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2717627},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707399,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class B Common Stock","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":2717627,"price":124,"value":336985748.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the \"Merger Agreement\"), by and among (i) the Issuer, (ii) GlaxoSmithKline LLC (\"Parent\"), (iii) Harmony Row Acquisition Co. (\"Purchaser\") and (iv) solely for purposes of Section 9.14 therein, GSK plc, upon the effective time of the merger contemplated thereby (the \"Merger\") each share of Class A Common Stock and each share of Class B Common Stock beneficially owned by the Reporting Persons was cancelled and converted into the right to receive $124.00, in cash. The disposition or deemed disposition of such securities by the Reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Prior to the consummation of the Merger, the Class B Common Stock was convertible into Class A Common Stock from time to time at the election of the holder, except that conversion was prohibited to the extent that, upon such conversion, the holder, its affiliates and other persons whose ownership of Class A Common Stock would be aggregated with that of such holder for purposes of Section 13(d) of the Securities Exchange Act of 1934, as amended, would exceed 4.9% of the total number of shares of Class A Common Stock then outstanding."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Class A Common Stock","underlying_shares":2717627},"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707398,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock - Restricted Stock Units","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":3444,"price":124,"value":427056.0,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F5","text":"The reported shares of Class A Common Stock were issuable under restricted stock units (\"RSUs\") granted to Dr. Wheeler, which were held for the benefit, and at the direction, of Deerfield Management. Pursuant to the Merger Agreement, each of the reported RSUs was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to (or deliverable under) such RSU immediately prior to the effective time of the Merger and (y) $124.00. The disposition or deemed disposition of such securities pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The reported shares of Class A Common Stock were issuable under restricted stock units (\"RSUs\") granted to Dr. Wheeler, which were held for the benefit, and at the direction, of Deerfield Management. Pursuant to the Merger Agreement, each of the reported RSUs was cancelled and converted into the right of the holder to receive an amount in cash (without interest and less applicable withholding taxes) equal to the product of (x) the total number of shares subject to (or deliverable under) such RSU immediately prior to the effective time of the Merger and (y) $124.00. The disposition or deemed disposition of such securities pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Prior to the consummation of the transactions contemplated by the Merger Agreement, Cameron Wheeler, a partner in Deerfield Management Company, L.P. (\"Deerfield Management\"), served as a director of the Issuer. The reported shares of Class A Common Stock, RSUs (as defined below) and stock options were held by Dr. Wheeler for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707397,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"other","planned":false,"acquired":false,"shares":5146,"price":124,"value":638104.0,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, on July 15, 2026, Purchaser completed a tender offer (the \"Offer\") to purchase all outstanding shares of the Issuer's Class A Common Stock and Class B Common Stock. The reported shares were tendered to, and accepted by, the Purchaser in exchange for the offer price of $124.00 per share, in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, on July 15, 2026, Purchaser completed a tender offer (the \"Offer\") to purchase all outstanding shares of the Issuer's Class A Common Stock and Class B Common Stock. The reported shares were tendered to, and accepted by, the Purchaser in exchange for the offer price of $124.00 per share, in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"Prior to his resignation from the board of directors of the Issuer in connection with the Issuer's 2026 annual meeting of stockholders, Joseph Pearlberg, an employee of Deerfield Management, served as a director of the Issuer. The reported shares of Class A Common Stock and stock options were held by Mr. Pearlberg for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707396,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"other","planned":false,"acquired":false,"shares":5146,"price":124,"value":638104.0,"ownership":{"direct":false,"nature":"Through Deerfield Mangement Company, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Pursuant to the Merger Agreement, on July 15, 2026, Purchaser completed a tender offer (the \"Offer\") to purchase all outstanding shares of the Issuer's Class A Common Stock and Class B Common Stock. The reported shares were tendered to, and accepted by, the Purchaser in exchange for the offer price of $124.00 per share, in cash."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Pursuant to the Merger Agreement, on July 15, 2026, Purchaser completed a tender offer (the \"Offer\") to purchase all outstanding shares of the Issuer's Class A Common Stock and Class B Common Stock. The reported shares were tendered to, and accepted by, the Purchaser in exchange for the offer price of $124.00 per share, in cash."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"Prior to the consummation of the transactions contemplated by the Merger Agreement, Cameron Wheeler, a partner in Deerfield Management Company, L.P. (\"Deerfield Management\"), served as a director of the Issuer. The reported shares of Class A Common Stock, RSUs (as defined below) and stock options were held by Dr. Wheeler for the benefit, and at the direction, of Deerfield Management."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707395,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":650000,"price":124,"value":80600000.0,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the \"Merger Agreement\"), by and among (i) the Issuer, (ii) GlaxoSmithKline LLC (\"Parent\"), (iii) Harmony Row Acquisition Co. (\"Purchaser\") and (iv) solely for purposes of Section 9.14 therein, GSK plc, upon the effective time of the merger contemplated thereby (the \"Merger\") each share of Class A Common Stock and each share of Class B Common Stock beneficially owned by the Reporting Persons was cancelled and converted into the right to receive $124.00, in cash. The disposition or deemed disposition of such securities by the Reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the \"Merger Agreement\"), by and among (i) the Issuer, (ii) GlaxoSmithKline LLC (\"Parent\"), (iii) Harmony Row Acquisition Co. (\"Purchaser\") and (iv) solely for purposes of Section 9.14 therein, GSK plc, upon the effective time of the merger contemplated thereby (the \"Merger\") each share of Class A Common Stock and each share of Class B Common Stock beneficially owned by the Reporting Persons was cancelled and converted into the right to receive $124.00, in cash. The disposition or deemed disposition of such securities by the Reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707394,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8299225,"price":124,"value":1029103900.0,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the \"Merger Agreement\"), by and among (i) the Issuer, (ii) GlaxoSmithKline LLC (\"Parent\"), (iii) Harmony Row Acquisition Co. (\"Purchaser\") and (iv) solely for purposes of Section 9.14 therein, GSK plc, upon the effective time of the merger contemplated thereby (the \"Merger\") each share of Class A Common Stock and each share of Class B Common Stock beneficially owned by the Reporting Persons was cancelled and converted into the right to receive $124.00, in cash. The disposition or deemed disposition of such securities by the Reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the \"Merger Agreement\"), by and among (i) the Issuer, (ii) GlaxoSmithKline LLC (\"Parent\"), (iii) Harmony Row Acquisition Co. (\"Purchaser\") and (iv) solely for purposes of Section 9.14 therein, GSK plc, upon the effective time of the merger contemplated thereby (the \"Merger\") each share of Class A Common Stock and each share of Class B Common Stock beneficially owned by the Reporting Persons was cancelled and converted into the right to receive $124.00, in cash. The disposition or deemed disposition of such securities by the Reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":707393,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2026-07-17T19:27:17.000Z","date":"2026-07-15","kind":"disposition_to_issuer","planned":false,"acquired":false,"shares":8299225,"price":124,"value":1029103900.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the \"Merger Agreement\"), by and among (i) the Issuer, (ii) GlaxoSmithKline LLC (\"Parent\"), (iii) Harmony Row Acquisition Co. (\"Purchaser\") and (iv) solely for purposes of Section 9.14 therein, GSK plc, upon the effective time of the merger contemplated thereby (the \"Merger\") each share of Class A Common Stock and each share of Class B Common Stock beneficially owned by the Reporting Persons was cancelled and converted into the right to receive $124.00, in cash. The disposition or deemed disposition of such securities by the Reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Pursuant to the Agreement and Plan of Merger, dated June 9, 2026 (the \"Merger Agreement\"), by and among (i) the Issuer, (ii) GlaxoSmithKline LLC (\"Parent\"), (iii) Harmony Row Acquisition Co. (\"Purchaser\") and (iv) solely for purposes of Section 9.14 therein, GSK plc, upon the effective time of the merger contemplated thereby (the \"Merger\") each share of Class A Common Stock and each share of Class B Common Stock beneficially owned by the Reporting Persons was cancelled and converted into the right to receive $124.00, in cash. The disposition or deemed disposition of such securities by the Reporting Persons pursuant to the Merger Agreement was exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F8","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F9","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001193805-26-000978","document":"e665657_4-nuvl.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000978/e665657_4-nuvl.xml","form_type":"4"}},{"id":742234,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series D Preferred Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":464550,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Voting Common Stock","underlying_shares":407132},"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742233,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series D Preferred Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":464550,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Voting Common Stock","underlying_shares":407132},"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742232,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series C Preferred Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":246732,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Voting Common Stock","underlying_shares":260992},"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742231,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series C Preferred Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":246732,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Voting Common Stock","underlying_shares":260992},"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742230,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series B Preferred Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":143650,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Voting Common Stock","underlying_shares":149238},"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742229,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series B Preferred Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":143650,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Voting Common Stock","underlying_shares":149238},"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742228,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series A Preferred Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":166070,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Voting Common Stock","underlying_shares":122990},"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742227,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Series A Preferred Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":false,"shares":166070,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":0,"derivative":{"underlying":"Voting Common Stock","underlying_shares":122990},"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742226,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Voting Common Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":407132,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":940352,"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742225,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Voting Common Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":407132,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each share of Series D Preferred Stock automatically converted into approximately 0.8764 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":940352,"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742224,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Voting Common Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":260992,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":533220,"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742223,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Voting Common Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":260992,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each share of Series C Preferred Stock automatically converted into approximately 1.0578 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":533220,"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742222,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Voting Common Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":149238,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":272228,"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742221,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Voting Common Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":149238,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each share of Series B Preferred Stock automatically converted into approximately 1.0389 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":272228,"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742220,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Voting Common Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":122990,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":122990,"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":742219,"issuer":{"id":3933,"kind":"organization","name":"Parabilis Medicines, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":5,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":6,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Voting Common Stock","published_at":"2026-06-12T00:07:47.000Z","date":"2026-06-11","kind":"exercise","planned":false,"acquired":true,"shares":122990,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Series A Preferred Stock automatically converted into approximately 0.7406 shares of the Issuer's voting common stock upon the closing of the Issuer's initial public offering (on an adjusted basis after giving effect to the 1-for-1.5389 reverse split of the Issuer's common stock effected by the Issuer on June 3, 2026)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield Innovations\" and together with Fund III, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F6","text":"In accordance with Instruction 4(b)(iv) to Form 4, the entire amount of the Issuer's securities held by each Fund is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":122990,"source":{"system":"sec-edgar","filing":"0001193805-26-000798","document":"e665575_4-pbls.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000798/e665575_4-pbls.xml","form_type":"4"}},{"id":875272,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2026-03-03T00:46:04.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":2000000,"price":5,"value":10000000.0,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":6207982,"source":{"system":"sec-edgar","filing":"0001193805-26-000205","document":"e665206_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000205/e665206_4-larimar.xml","form_type":"4"}},{"id":875271,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2026-03-03T00:46:04.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":831978,"price":5,"value":4159890.0,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":8153107,"source":{"system":"sec-edgar","filing":"0001193805-26-000205","document":"e665206_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000205/e665206_4-larimar.xml","form_type":"4"}},{"id":875270,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2026-03-03T00:46:04.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":1084012,"price":5,"value":5420060.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":10622957,"source":{"system":"sec-edgar","filing":"0001193805-26-000205","document":"e665206_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000205/e665206_4-larimar.xml","form_type":"4"}},{"id":875269,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2026-03-03T00:46:04.000Z","date":"2026-02-27","kind":"purchase","planned":false,"acquired":true,"shares":1084010,"price":5,"value":5420050.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":10622928,"source":{"system":"sec-edgar","filing":"0001193805-26-000205","document":"e665206_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380526000205/e665206_4-larimar.xml","form_type":"4"}},{"id":990577,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2025-11-25T01:00:57.000Z","date":"2025-11-24","kind":"sale","planned":false,"acquired":false,"shares":371287,"price":95.445,"value":35437487.715,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Class A Common Stock were sold to underwriters pursuant to the exercise of the underwriters' option to purchase shares of Class A Common Stock from Deerfield Private Design Fund IV, L.P. and Deerfield Healthcare Innovations Fund, L.P., at a price per share of $95.445, to cover over-allotments in an underwritten public offering. The shares were sold to the public in the offering at a price of $101.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":8299225,"source":{"system":"sec-edgar","filing":"0001193805-25-001648","document":"e665003_4-nuvl.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525001648/e665003_4-nuvl.xml","form_type":"4"}},{"id":990576,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Director by Deputization"}}],"security":"Class A Common Stock","published_at":"2025-11-25T01:00:57.000Z","date":"2025-11-24","kind":"sale","planned":false,"acquired":false,"shares":371287,"price":95.445,"value":35437487.715,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The shares of Class A Common Stock were sold to underwriters pursuant to the exercise of the underwriters' option to purchase shares of Class A Common Stock from Deerfield Private Design Fund IV, L.P. and Deerfield Healthcare Innovations Fund, L.P., at a price per share of $95.445, to cover over-allotments in an underwritten public offering. The shares were sold to the public in the offering at a price of $101.00 per share."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":8299225,"source":{"system":"sec-edgar","filing":"0001193805-25-001648","document":"e665003_4-nuvl.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525001648/e665003_4-nuvl.xml","form_type":"4"}},{"id":1076729,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2025-08-04T22:28:33.000Z","date":"2025-07-31","kind":"purchase","planned":false,"acquired":true,"shares":2599932,"price":3.2,"value":8319782.4,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":7321129,"source":{"system":"sec-edgar","filing":"0001193805-25-001155","document":"e664762_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525001155/e664762_4-larimar.xml","form_type":"4"}},{"id":1076728,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2025-08-04T22:28:33.000Z","date":"2025-07-31","kind":"purchase","planned":false,"acquired":true,"shares":3387539,"price":3.2,"value":10840124.8,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":9538945,"source":{"system":"sec-edgar","filing":"0001193805-25-001155","document":"e664762_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525001155/e664762_4-larimar.xml","form_type":"4"}},{"id":1076727,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2025-08-04T22:28:33.000Z","date":"2025-07-31","kind":"purchase","planned":false,"acquired":true,"shares":3387529,"price":3.2,"value":10840092.8,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole manager of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":9538918,"source":{"system":"sec-edgar","filing":"0001193805-25-001155","document":"e664762_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525001155/e664762_4-larimar.xml","form_type":"4"}},{"id":1167310,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}}],"security":"Warrants","published_at":"2025-04-23T21:49:02.000Z","date":"2025-04-21","kind":"grant","planned":false,"acquired":true,"shares":1611864,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported Warrants were originally issued on February 27, 2025 pursuant to the Inducement Letter Agreement described in Footnote 1 to the Form 4 filed by the Reporting Persons on March 3, 2025, but such Warrants were not exercisable unless and until requisite approval of the Issuer's stockholder had been obtained. Such approval was obtained on April 21, 2025, whereupon the Warrants became exercisable in accordance with their terms. The acquisition or deemed acquisition of such securities and any shares of Common Stock that may be acquired upon exercise of such Warrants were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported Warrants were originally issued on February 27, 2025 pursuant to the Inducement Letter Agreement described in Footnote 1 to the Form 4 filed by the Reporting Persons on March 3, 2025, but such Warrants were not exercisable unless and until requisite approval of the Issuer's stockholder had been obtained. Such approval was obtained on April 21, 2025, whereupon the Warrants became exercisable in accordance with their terms. The acquisition or deemed acquisition of such securities and any shares of Common Stock that may be acquired upon exercise of such Warrants were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of Deerfield Private Design Fund V, L.P. (\"DPD V\"). Deerfield Mgmt HIF II, L.P. is the general partner of Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and, together with DPD V, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1611864,"derivative":{"exercise_price":0.9306,"expiration_date":"2030-04-21","underlying":"Common Stock","underlying_shares":1611864},"source":{"system":"sec-edgar","filing":"0001193805-25-000549","document":"e664432_4-biomx.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525000549/e664432_4-biomx.xml","form_type":"4"}},{"id":1167309,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}}],"security":"Warrants","published_at":"2025-04-23T21:49:02.000Z","date":"2025-04-21","kind":"grant","planned":false,"acquired":true,"shares":1611864,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund V, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The reported Warrants were originally issued on February 27, 2025 pursuant to the Inducement Letter Agreement described in Footnote 1 to the Form 4 filed by the Reporting Persons on March 3, 2025, but such Warrants were not exercisable unless and until requisite approval of the Issuer's stockholder had been obtained. Such approval was obtained on April 21, 2025, whereupon the Warrants became exercisable in accordance with their terms. The acquisition or deemed acquisition of such securities and any shares of Common Stock that may be acquired upon exercise of such Warrants were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The reported Warrants were originally issued on February 27, 2025 pursuant to the Inducement Letter Agreement described in Footnote 1 to the Form 4 filed by the Reporting Persons on March 3, 2025, but such Warrants were not exercisable unless and until requisite approval of the Issuer's stockholder had been obtained. Such approval was obtained on April 21, 2025, whereupon the Warrants became exercisable in accordance with their terms. The acquisition or deemed acquisition of such securities and any shares of Common Stock that may be acquired upon exercise of such Warrants were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of Deerfield Private Design Fund V, L.P. (\"DPD V\"). Deerfield Mgmt HIF II, L.P. is the general partner of Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and, together with DPD V, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1611864,"derivative":{"exercise_price":0.9306,"expiration_date":"2030-04-21","underlying":"Common Stock","underlying_shares":1611864},"source":{"system":"sec-edgar","filing":"0001193805-25-000549","document":"e664432_4-biomx.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525000549/e664432_4-biomx.xml","form_type":"4"}},{"id":1236861,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}}],"security":"Warrants","published_at":"2025-03-04T00:02:52.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":1258614,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with exercise of the Private Placement Warrants pursuant to the Inducement Letter Agreements, each Fund's Private Placement Warrant was amended and restated in respect of 1,258,614 of the underlying shares, to (i) reduce the exercise price from $2.311 per share to $0.0001 per share (in addition to $0.9305 per share that was pre-funded in connection with the exercise of the Private Placement Warrants pursuant to the Inducement Letter Agreements), (ii) extend the Expiration Date (as defined in the Private Placement Warrants) from 24 months after the initial exercisability date until such time that the Private Placement Warrants are exercised in full, and (iii) to remove from Section 4(b) such provisions as related to the Black-Scholes Value (as defined in the Private Placement Warrants) as related to any Fundamental Transactions (as defined in the Private Placement Warrants) undertaken by the Company."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 27, 2025, each of Deerfield Private Design Fund V, L.P. (\"DPD V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and together with DPD V, the \"Funds\" and each a \"Fund\") exercised its Private Placement Warrant (as defined in the Form 4 filed by the Reporting Persons on July 9, 2024 with respect to the Issuer) for cash in respect of 1,611,864 shares of Common Stock (the \"Exercise Shares\"), pursuant to a letter agreement, dated as of February 25, 2025 (each an \"Inducement Letter Agreement\"), between such Fund and the Company. Pursuant to each Inducement Letter Agreement, each such exercise was effected at a reduced exercise price of $0.9306 per share in consideration for the issuance by the Company to such Fund of a new warrant (each, a \"New Warrant\") to purchase up to 1,611,864 shares of Common Stock (the \"New Warrant Shares\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"To the extent the exercise of a Private Placement Warrant in accordance with an Inducement Letter Agreement would otherwise have resulted in the issuance of a number of shares of Common Stock in excess of the number of shares of Common Stock that the Funds could acquire without exceeding the beneficial ownership limitations (\"Beneficial Ownership Limitation\") set forth in the Private Placement Warrants, pursuant to the Inducement Letter Agreement, on February 27, 202 (i) the Company issued to each Fund 353,249 shares of Common Stock (representing the maximum number of shares of Common Stock that each Fund was entitled to receive without exceeding the Beneficial Ownership Limitation), and (ii) in lieu of issuing the remaining 1,258,614 shares of Common Stock for which each Fund exercised its Private Placement Warrant, amended and restated the portion of the Private Placement Warrant exercisable for such excess shares as set forth in the Amended and Restated Warrant (as defined below)."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with exercise of the Private Placement Warrants pursuant to the Inducement Letter Agreements, each Fund's Private Placement Warrant was amended and restated in respect of 1,258,614 of the underlying shares, to (i) reduce the exercise price from $2.311 per share to $0.0001 per share (in addition to $0.9305 per share that was pre-funded in connection with the exercise of the Private Placement Warrants pursuant to the Inducement Letter Agreements), (ii) extend the Expiration Date (as defined in the Private Placement Warrants) from 24 months after the initial exercisability date until such time that the Private Placement Warrants are exercised in full, and (iii) to remove from Section 4(b) such provisions as related to the Black-Scholes Value (as defined in the Private Placement Warrants) as related to any Fundamental Transactions (as defined in the Private Placement Warrants) undertaken by the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with exercise of the Private Placement Warrants pursuant to the Inducement Letter Agreements, each Fund's Private Placement Warrant was amended and restated in respect of 1,258,614 of the underlying shares, to (i) reduce the exercise price from $2.311 per share to $0.0001 per share (in addition to $0.9305 per share that was pre-funded in connection with the exercise of the Private Placement Warrants pursuant to the Inducement Letter Agreements), (ii) extend the Expiration Date (as defined in the Private Placement Warrants) from 24 months after the initial exercisability date until such time that the Private Placement Warrants are exercised in full, and (iii) to remove from Section 4(b) such provisions as related to the Black-Scholes Value (as defined in the Private Placement Warrants) as related to any Fundamental Transactions (as defined in the Private Placement Warrants) undertaken by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with exercise of the Private Placement Warrants pursuant to the Inducement Letter Agreements, each Fund's Private Placement Warrant was amended and restated in respect of 1,258,614 of the underlying shares, to (i) reduce the exercise price from $2.311 per share to $0.0001 per share (in addition to $0.9305 per share that was pre-funded in connection with the exercise of the Private Placement Warrants pursuant to the Inducement Letter Agreements), (ii) extend the Expiration Date (as defined in the Private Placement Warrants) from 24 months after the initial exercisability date until such time that the Private Placement Warrants are exercised in full, and (iii) to remove from Section 4(b) such provisions as related to the Black-Scholes Value (as defined in the Private Placement Warrants) as related to any Fundamental Transactions (as defined in the Private Placement Warrants) undertaken by the Company."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of DPD V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P. The New Warrants have an exercise price of $0.9306 per share and have a five-year term commencing on the date the New Warrants become exercisable (if at all). The New Warrants are not currently exercisable and will not become exercisable unless and until requisite stockholder approval is obtained. Accordingly, the New Warrants are not reported herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1258614,"derivative":{"underlying":"Common Stock","underlying_shares":1258614},"source":{"system":"sec-edgar","filing":"0001193805-25-000258","document":"e664242_4-biomx.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525000258/e664242_4-biomx.xml","form_type":"4"}},{"id":1236860,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}}],"security":"Warrants","published_at":"2025-03-04T00:02:52.000Z","date":"2025-02-27","kind":"grant","planned":false,"acquired":true,"shares":1258614,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F6","text":"In connection with exercise of the Private Placement Warrants pursuant to the Inducement Letter Agreements, each Fund's Private Placement Warrant was amended and restated in respect of 1,258,614 of the underlying shares, to (i) reduce the exercise price from $2.311 per share to $0.0001 per share (in addition to $0.9305 per share that was pre-funded in connection with the exercise of the Private Placement Warrants pursuant to the Inducement Letter Agreements), (ii) extend the Expiration Date (as defined in the Private Placement Warrants) from 24 months after the initial exercisability date until such time that the Private Placement Warrants are exercised in full, and (iii) to remove from Section 4(b) such provisions as related to the Black-Scholes Value (as defined in the Private Placement Warrants) as related to any Fundamental Transactions (as defined in the Private Placement Warrants) undertaken by the Company."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 27, 2025, each of Deerfield Private Design Fund V, L.P. (\"DPD V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and together with DPD V, the \"Funds\" and each a \"Fund\") exercised its Private Placement Warrant (as defined in the Form 4 filed by the Reporting Persons on July 9, 2024 with respect to the Issuer) for cash in respect of 1,611,864 shares of Common Stock (the \"Exercise Shares\"), pursuant to a letter agreement, dated as of February 25, 2025 (each an \"Inducement Letter Agreement\"), between such Fund and the Company. Pursuant to each Inducement Letter Agreement, each such exercise was effected at a reduced exercise price of $0.9306 per share in consideration for the issuance by the Company to such Fund of a new warrant (each, a \"New Warrant\") to purchase up to 1,611,864 shares of Common Stock (the \"New Warrant Shares\")."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"To the extent the exercise of a Private Placement Warrant in accordance with an Inducement Letter Agreement would otherwise have resulted in the issuance of a number of shares of Common Stock in excess of the number of shares of Common Stock that the Funds could acquire without exceeding the beneficial ownership limitations (\"Beneficial Ownership Limitation\") set forth in the Private Placement Warrants, pursuant to the Inducement Letter Agreement, on February 27, 202 (i) the Company issued to each Fund 353,249 shares of Common Stock (representing the maximum number of shares of Common Stock that each Fund was entitled to receive without exceeding the Beneficial Ownership Limitation), and (ii) in lieu of issuing the remaining 1,258,614 shares of Common Stock for which each Fund exercised its Private Placement Warrant, amended and restated the portion of the Private Placement Warrant exercisable for such excess shares as set forth in the Amended and Restated Warrant (as defined below)."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"In connection with exercise of the Private Placement Warrants pursuant to the Inducement Letter Agreements, each Fund's Private Placement Warrant was amended and restated in respect of 1,258,614 of the underlying shares, to (i) reduce the exercise price from $2.311 per share to $0.0001 per share (in addition to $0.9305 per share that was pre-funded in connection with the exercise of the Private Placement Warrants pursuant to the Inducement Letter Agreements), (ii) extend the Expiration Date (as defined in the Private Placement Warrants) from 24 months after the initial exercisability date until such time that the Private Placement Warrants are exercised in full, and (iii) to remove from Section 4(b) such provisions as related to the Black-Scholes Value (as defined in the Private Placement Warrants) as related to any Fundamental Transactions (as defined in the Private Placement Warrants) undertaken by the Company."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"In connection with exercise of the Private Placement Warrants pursuant to the Inducement Letter Agreements, each Fund's Private Placement Warrant was amended and restated in respect of 1,258,614 of the underlying shares, to (i) reduce the exercise price from $2.311 per share to $0.0001 per share (in addition to $0.9305 per share that was pre-funded in connection with the exercise of the Private Placement Warrants pursuant to the Inducement Letter Agreements), (ii) extend the Expiration Date (as defined in the Private Placement Warrants) from 24 months after the initial exercisability date until such time that the Private Placement Warrants are exercised in full, and (iii) to remove from Section 4(b) such provisions as related to the Black-Scholes Value (as defined in the Private Placement Warrants) as related to any Fundamental Transactions (as defined in the Private Placement Warrants) undertaken by the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"In connection with exercise of the Private Placement Warrants pursuant to the Inducement Letter Agreements, each Fund's Private Placement Warrant was amended and restated in respect of 1,258,614 of the underlying shares, to (i) reduce the exercise price from $2.311 per share to $0.0001 per share (in addition to $0.9305 per share that was pre-funded in connection with the exercise of the Private Placement Warrants pursuant to the Inducement Letter Agreements), (ii) extend the Expiration Date (as defined in the Private Placement Warrants) from 24 months after the initial exercisability date until such time that the Private Placement Warrants are exercised in full, and (iii) to remove from Section 4(b) such provisions as related to the Black-Scholes Value (as defined in the Private Placement Warrants) as related to any Fundamental Transactions (as defined in the Private Placement Warrants) undertaken by the Company."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of DPD V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P. The New Warrants have an exercise price of $0.9306 per share and have a five-year term commencing on the date the New Warrants become exercisable (if at all). The New Warrants are not currently exercisable and will not become exercisable unless and until requisite stockholder approval is obtained. Accordingly, the New Warrants are not reported herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1258614,"derivative":{"underlying":"Common Stock","underlying_shares":1258614},"source":{"system":"sec-edgar","filing":"0001193805-25-000258","document":"e664242_4-biomx.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525000258/e664242_4-biomx.xml","form_type":"4"}},{"id":1236859,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}}],"security":"Warrants","published_at":"2025-03-04T00:02:52.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":false,"shares":1611863,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On February 27, 2025, each of Deerfield Private Design Fund V, L.P. (\"DPD V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and together with DPD V, the \"Funds\" and each a \"Fund\") exercised its Private Placement Warrant (as defined in the Form 4 filed by the Reporting Persons on July 9, 2024 with respect to the Issuer) for cash in respect of 1,611,864 shares of Common Stock (the \"Exercise Shares\"), pursuant to a letter agreement, dated as of February 25, 2025 (each an \"Inducement Letter Agreement\"), between such Fund and the Company. Pursuant to each Inducement Letter Agreement, each such exercise was effected at a reduced exercise price of $0.9306 per share in consideration for the issuance by the Company to such Fund of a new warrant (each, a \"New Warrant\") to purchase up to 1,611,864 shares of Common Stock (the \"New Warrant Shares\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"To the extent the exercise of a Private Placement Warrant in accordance with an Inducement Letter Agreement would otherwise have resulted in the issuance of a number of shares of Common Stock in excess of the number of shares of Common Stock that the Funds could acquire without exceeding the beneficial ownership limitations (\"Beneficial Ownership Limitation\") set forth in the Private Placement Warrants, pursuant to the Inducement Letter Agreement, on February 27, 202 (i) the Company issued to each Fund 353,249 shares of Common Stock (representing the maximum number of shares of Common Stock that each Fund was entitled to receive without exceeding the Beneficial Ownership Limitation), and (ii) in lieu of issuing the remaining 1,258,614 shares of Common Stock for which each Fund exercised its Private Placement Warrant, amended and restated the portion of the Private Placement Warrant exercisable for such excess shares as set forth in the Amended and Restated Warrant (as defined below)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 27, 2025, each of Deerfield Private Design Fund V, L.P. (\"DPD V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and together with DPD V, the \"Funds\" and each a \"Fund\") exercised its Private Placement Warrant (as defined in the Form 4 filed by the Reporting Persons on July 9, 2024 with respect to the Issuer) for cash in respect of 1,611,864 shares of Common Stock (the \"Exercise Shares\"), pursuant to a letter agreement, dated as of February 25, 2025 (each an \"Inducement Letter Agreement\"), between such Fund and the Company. Pursuant to each Inducement Letter Agreement, each such exercise was effected at a reduced exercise price of $0.9306 per share in consideration for the issuance by the Company to such Fund of a new warrant (each, a \"New Warrant\") to purchase up to 1,611,864 shares of Common Stock (the \"New Warrant Shares\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The unexercised portion of each Private Placement Warrant held by a Fund was not amended in connection with the transactions reported herein and remains exercisable for $2.311 per share upon the terms, and subject to the conditions, set forth therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of DPD V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P. The New Warrants have an exercise price of $0.9306 per share and have a five-year term commencing on the date the New Warrants become exercisable (if at all). The New Warrants are not currently exercisable and will not become exercisable unless and until requisite stockholder approval is obtained. Accordingly, the New Warrants are not reported herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":405637,"derivative":{"exercise_date":"2024-07-09","expiration_date":"2026-07-09","underlying":"Common Stock","underlying_shares":1611863},"source":{"system":"sec-edgar","filing":"0001193805-25-000258","document":"e664242_4-biomx.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525000258/e664242_4-biomx.xml","form_type":"4"}},{"id":1236858,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}}],"security":"Warrants","published_at":"2025-03-04T00:02:52.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":false,"shares":1611863,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"On February 27, 2025, each of Deerfield Private Design Fund V, L.P. (\"DPD V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and together with DPD V, the \"Funds\" and each a \"Fund\") exercised its Private Placement Warrant (as defined in the Form 4 filed by the Reporting Persons on July 9, 2024 with respect to the Issuer) for cash in respect of 1,611,864 shares of Common Stock (the \"Exercise Shares\"), pursuant to a letter agreement, dated as of February 25, 2025 (each an \"Inducement Letter Agreement\"), between such Fund and the Company. Pursuant to each Inducement Letter Agreement, each such exercise was effected at a reduced exercise price of $0.9306 per share in consideration for the issuance by the Company to such Fund of a new warrant (each, a \"New Warrant\") to purchase up to 1,611,864 shares of Common Stock (the \"New Warrant Shares\")."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"To the extent the exercise of a Private Placement Warrant in accordance with an Inducement Letter Agreement would otherwise have resulted in the issuance of a number of shares of Common Stock in excess of the number of shares of Common Stock that the Funds could acquire without exceeding the beneficial ownership limitations (\"Beneficial Ownership Limitation\") set forth in the Private Placement Warrants, pursuant to the Inducement Letter Agreement, on February 27, 202 (i) the Company issued to each Fund 353,249 shares of Common Stock (representing the maximum number of shares of Common Stock that each Fund was entitled to receive without exceeding the Beneficial Ownership Limitation), and (ii) in lieu of issuing the remaining 1,258,614 shares of Common Stock for which each Fund exercised its Private Placement Warrant, amended and restated the portion of the Private Placement Warrant exercisable for such excess shares as set forth in the Amended and Restated Warrant (as defined below)."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On February 27, 2025, each of Deerfield Private Design Fund V, L.P. (\"DPD V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and together with DPD V, the \"Funds\" and each a \"Fund\") exercised its Private Placement Warrant (as defined in the Form 4 filed by the Reporting Persons on July 9, 2024 with respect to the Issuer) for cash in respect of 1,611,864 shares of Common Stock (the \"Exercise Shares\"), pursuant to a letter agreement, dated as of February 25, 2025 (each an \"Inducement Letter Agreement\"), between such Fund and the Company. Pursuant to each Inducement Letter Agreement, each such exercise was effected at a reduced exercise price of $0.9306 per share in consideration for the issuance by the Company to such Fund of a new warrant (each, a \"New Warrant\") to purchase up to 1,611,864 shares of Common Stock (the \"New Warrant Shares\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F5","text":"The unexercised portion of each Private Placement Warrant held by a Fund was not amended in connection with the transactions reported herein and remains exercisable for $2.311 per share upon the terms, and subject to the conditions, set forth therein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of DPD V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P. The New Warrants have an exercise price of $0.9306 per share and have a five-year term commencing on the date the New Warrants become exercisable (if at all). The New Warrants are not currently exercisable and will not become exercisable unless and until requisite stockholder approval is obtained. Accordingly, the New Warrants are not reported herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":405637,"derivative":{"exercise_date":"2024-07-09","expiration_date":"2026-07-09","underlying":"Common Stock","underlying_shares":1611863},"source":{"system":"sec-edgar","filing":"0001193805-25-000258","document":"e664242_4-biomx.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525000258/e664242_4-biomx.xml","form_type":"4"}},{"id":1236857,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}}],"security":"Common Stock","published_at":"2025-03-04T00:02:52.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":true,"shares":353249,"price":0.9306,"value":328733.5194,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 27, 2025, each of Deerfield Private Design Fund V, L.P. (\"DPD V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and together with DPD V, the \"Funds\" and each a \"Fund\") exercised its Private Placement Warrant (as defined in the Form 4 filed by the Reporting Persons on July 9, 2024 with respect to the Issuer) for cash in respect of 1,611,864 shares of Common Stock (the \"Exercise Shares\"), pursuant to a letter agreement, dated as of February 25, 2025 (each an \"Inducement Letter Agreement\"), between such Fund and the Company. Pursuant to each Inducement Letter Agreement, each such exercise was effected at a reduced exercise price of $0.9306 per share in consideration for the issuance by the Company to such Fund of a new warrant (each, a \"New Warrant\") to purchase up to 1,611,864 shares of Common Stock (the \"New Warrant Shares\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"To the extent the exercise of a Private Placement Warrant in accordance with an Inducement Letter Agreement would otherwise have resulted in the issuance of a number of shares of Common Stock in excess of the number of shares of Common Stock that the Funds could acquire without exceeding the beneficial ownership limitations (\"Beneficial Ownership Limitation\") set forth in the Private Placement Warrants, pursuant to the Inducement Letter Agreement, on February 27, 202 (i) the Company issued to each Fund 353,249 shares of Common Stock (representing the maximum number of shares of Common Stock that each Fund was entitled to receive without exceeding the Beneficial Ownership Limitation), and (ii) in lieu of issuing the remaining 1,258,614 shares of Common Stock for which each Fund exercised its Private Placement Warrant, amended and restated the portion of the Private Placement Warrant exercisable for such excess shares as set forth in the Amended and Restated Warrant (as defined below)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of DPD V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P. The New Warrants have an exercise price of $0.9306 per share and have a five-year term commencing on the date the New Warrants become exercisable (if at all). The New Warrants are not currently exercisable and will not become exercisable unless and until requisite stockholder approval is obtained. Accordingly, the New Warrants are not reported herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1247054,"source":{"system":"sec-edgar","filing":"0001193805-25-000258","document":"e664242_4-biomx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525000258/e664242_4-biomx.xml","form_type":"4"}},{"id":1236856,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}}],"security":"Common Stock","published_at":"2025-03-04T00:02:52.000Z","date":"2025-02-27","kind":"exercise","planned":false,"acquired":true,"shares":353249,"price":0.9306,"value":328733.5194,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund V, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"On February 27, 2025, each of Deerfield Private Design Fund V, L.P. (\"DPD V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and together with DPD V, the \"Funds\" and each a \"Fund\") exercised its Private Placement Warrant (as defined in the Form 4 filed by the Reporting Persons on July 9, 2024 with respect to the Issuer) for cash in respect of 1,611,864 shares of Common Stock (the \"Exercise Shares\"), pursuant to a letter agreement, dated as of February 25, 2025 (each an \"Inducement Letter Agreement\"), between such Fund and the Company. Pursuant to each Inducement Letter Agreement, each such exercise was effected at a reduced exercise price of $0.9306 per share in consideration for the issuance by the Company to such Fund of a new warrant (each, a \"New Warrant\") to purchase up to 1,611,864 shares of Common Stock (the \"New Warrant Shares\")."},{"field":"kind","element":"transactionCoding","label":"F2","text":"To the extent the exercise of a Private Placement Warrant in accordance with an Inducement Letter Agreement would otherwise have resulted in the issuance of a number of shares of Common Stock in excess of the number of shares of Common Stock that the Funds could acquire without exceeding the beneficial ownership limitations (\"Beneficial Ownership Limitation\") set forth in the Private Placement Warrants, pursuant to the Inducement Letter Agreement, on February 27, 202 (i) the Company issued to each Fund 353,249 shares of Common Stock (representing the maximum number of shares of Common Stock that each Fund was entitled to receive without exceeding the Beneficial Ownership Limitation), and (ii) in lieu of issuing the remaining 1,258,614 shares of Common Stock for which each Fund exercised its Private Placement Warrant, amended and restated the portion of the Private Placement Warrant exercisable for such excess shares as set forth in the Amended and Restated Warrant (as defined below)."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of DPD V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P. The New Warrants have an exercise price of $0.9306 per share and have a five-year term commencing on the date the New Warrants become exercisable (if at all). The New Warrants are not currently exercisable and will not become exercisable unless and until requisite stockholder approval is obtained. Accordingly, the New Warrants are not reported herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1247054,"source":{"system":"sec-edgar","filing":"0001193805-25-000258","document":"e664242_4-biomx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380525000258/e664242_4-biomx.xml","form_type":"4"}},{"id":1382126,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}}],"security":"Class A Common Stock","published_at":"2024-10-24T20:08:04.000Z","date":"2024-10-22","kind":"sale","planned":false,"acquired":false,"shares":1000000,"price":97.75,"value":97750000.0,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":8670512,"source":{"system":"sec-edgar","filing":"0001193805-24-001275","document":"e663971_4-biomx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001275/e663971_4-biomx.xml","form_type":"4"}},{"id":1382125,"issuer":{"id":29892,"kind":"organization","name":"Nuvalent, Inc.","symbol":"NUVL"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":3,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":5,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":7,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":8,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by deputization"}}],"security":"Class A Common Stock","published_at":"2024-10-24T20:08:04.000Z","date":"2024-10-22","kind":"sale","planned":false,"acquired":false,"shares":1000000,"price":97.75,"value":97750000.0,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Deerfield Partners and Fund IV, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":8670512,"source":{"system":"sec-edgar","filing":"0001193805-24-001275","document":"e663971_4-biomx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524001275/e663971_4-biomx.xml","form_type":"4"}},{"id":1453051,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}}],"security":"Series X Non-Voting Convertible Preferred Stock","published_at":"2024-07-17T22:09:45.000Z","date":"2024-07-15","kind":"exercise","planned":false,"acquired":false,"shares":5883,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In accordance with the Certificate of Designation of Preferences, Rights and Limitations (the \"Certificate of Designation\") governing the Series X Non-voting Convertible Preferred Stock (\"Series X Preferred Stock\"), on July 15, 2024, 5,883 shares of Series X Preferred Stock held by each of Deerfield Private Design Fund V, L.P. (\"Fund V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and, together with Fund V, the \"Funds\") automatically converted into 5,883,000 shares of Common Stock. The acquisition or deemed acquisition of such shares of Common Stock upon such conversion, and any disposition or deemed disposition of such shares of Series X Preferred Stock upon such conversion, were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In accordance with the Certificate of Designation of Preferences, Rights and Limitations (the \"Certificate of Designation\") governing the Series X Non-voting Convertible Preferred Stock (\"Series X Preferred Stock\"), on July 15, 2024, 5,883 shares of Series X Preferred Stock held by each of Deerfield Private Design Fund V, L.P. (\"Fund V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and, together with Fund V, the \"Funds\") automatically converted into 5,883,000 shares of Common Stock. The acquisition or deemed acquisition of such shares of Common Stock upon such conversion, and any disposition or deemed disposition of such shares of Series X Preferred Stock upon such conversion, were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series X Preferred Stock is convertible at any time at the election of the holder, subject to a beneficial ownership limitation, into 1,000 shares of Common Stock (subject to adjustment) in accordance with the Certificate of Designation. The Series X Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series X Preferred Stock is convertible at any time at the election of the holder, subject to a beneficial ownership limitation, into 1,000 shares of Common Stock (subject to adjustment) in accordance with the Certificate of Designation. The Series X Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of Fund V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":47957,"derivative":{"underlying":"Common Stock","underlying_shares":5883000},"source":{"system":"sec-edgar","filing":"0001193805-24-000938","document":"e663787_4-biomx.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000938/e663787_4-biomx.xml","form_type":"4"}},{"id":1453050,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}}],"security":"Series X Non-Voting Convertible Preferred Stock","published_at":"2024-07-17T22:09:45.000Z","date":"2024-07-15","kind":"exercise","planned":false,"acquired":false,"shares":5883,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"In accordance with the Certificate of Designation of Preferences, Rights and Limitations (the \"Certificate of Designation\") governing the Series X Non-voting Convertible Preferred Stock (\"Series X Preferred Stock\"), on July 15, 2024, 5,883 shares of Series X Preferred Stock held by each of Deerfield Private Design Fund V, L.P. (\"Fund V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and, together with Fund V, the \"Funds\") automatically converted into 5,883,000 shares of Common Stock. The acquisition or deemed acquisition of such shares of Common Stock upon such conversion, and any disposition or deemed disposition of such shares of Series X Preferred Stock upon such conversion, were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In accordance with the Certificate of Designation of Preferences, Rights and Limitations (the \"Certificate of Designation\") governing the Series X Non-voting Convertible Preferred Stock (\"Series X Preferred Stock\"), on July 15, 2024, 5,883 shares of Series X Preferred Stock held by each of Deerfield Private Design Fund V, L.P. (\"Fund V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and, together with Fund V, the \"Funds\") automatically converted into 5,883,000 shares of Common Stock. The acquisition or deemed acquisition of such shares of Common Stock upon such conversion, and any disposition or deemed disposition of such shares of Series X Preferred Stock upon such conversion, were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Each share of Series X Preferred Stock is convertible at any time at the election of the holder, subject to a beneficial ownership limitation, into 1,000 shares of Common Stock (subject to adjustment) in accordance with the Certificate of Designation. The Series X Preferred Stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Each share of Series X Preferred Stock is convertible at any time at the election of the holder, subject to a beneficial ownership limitation, into 1,000 shares of Common Stock (subject to adjustment) in accordance with the Certificate of Designation. The Series X Preferred Stock has no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of Fund V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":47957,"derivative":{"underlying":"Common Stock","underlying_shares":5883000},"source":{"system":"sec-edgar","filing":"0001193805-24-000938","document":"e663787_4-biomx.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000938/e663787_4-biomx.xml","form_type":"4"}},{"id":1453049,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}}],"security":"Common Stock","published_at":"2024-07-17T22:09:45.000Z","date":"2024-07-15","kind":"exercise","planned":false,"acquired":true,"shares":5883000,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund II, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In accordance with the Certificate of Designation of Preferences, Rights and Limitations (the \"Certificate of Designation\") governing the Series X Non-voting Convertible Preferred Stock (\"Series X Preferred Stock\"), on July 15, 2024, 5,883 shares of Series X Preferred Stock held by each of Deerfield Private Design Fund V, L.P. (\"Fund V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and, together with Fund V, the \"Funds\") automatically converted into 5,883,000 shares of Common Stock. The acquisition or deemed acquisition of such shares of Common Stock upon such conversion, and any disposition or deemed disposition of such shares of Series X Preferred Stock upon such conversion, were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of Fund V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":8938049,"source":{"system":"sec-edgar","filing":"0001193805-24-000938","document":"e663787_4-biomx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000938/e663787_4-biomx.xml","form_type":"4"}},{"id":1453048,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":true,"other_text":"*Director by Deputization"}}],"security":"Common Stock","published_at":"2024-07-17T22:09:45.000Z","date":"2024-07-15","kind":"exercise","planned":false,"acquired":true,"shares":5883000,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund V, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"In accordance with the Certificate of Designation of Preferences, Rights and Limitations (the \"Certificate of Designation\") governing the Series X Non-voting Convertible Preferred Stock (\"Series X Preferred Stock\"), on July 15, 2024, 5,883 shares of Series X Preferred Stock held by each of Deerfield Private Design Fund V, L.P. (\"Fund V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and, together with Fund V, the \"Funds\") automatically converted into 5,883,000 shares of Common Stock. The acquisition or deemed acquisition of such shares of Common Stock upon such conversion, and any disposition or deemed disposition of such shares of Series X Preferred Stock upon such conversion, were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of Fund V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":8938049,"source":{"system":"sec-edgar","filing":"0001193805-24-000938","document":"e663787_4-biomx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000938/e663787_4-biomx.xml","form_type":"4"}},{"id":1456466,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}}],"security":"Warrants","published_at":"2024-07-11T22:47:07.000Z","date":"2024-07-09","kind":"grant","planned":false,"acquired":true,"shares":20175000,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund II, L.P."},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"On March 15, 2024, each Fund purchased 40,350 shares of Series X Preferred Stock and warrants to purchase 20,175,000 shares of Common Stock in a private placement at a combined purchase price of $231.10 per share of Series X Preferred Stock and warrant to purchase one-half of one share of Common Stock (subject to adjustment as provided in the warrants) (the \"Private Placement Warrants\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On March 15, 2024, each Fund purchased 40,350 shares of Series X Preferred Stock and warrants to purchase 20,175,000 shares of Common Stock in a private placement at a combined purchase price of $231.10 per share of Series X Preferred Stock and warrant to purchase one-half of one share of Common Stock (subject to adjustment as provided in the warrants) (the \"Private Placement Warrants\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Private Placement Warrants were originally issued on March 15, 2024, but were not exercisable unless and until requisite approval of the Issuer's stockholder had been obtained. Such approval was obtained on July 9, 2024, whereupon the Merger Warrants became exercisable in accordance with their terms. The acquisition or deemed acquisition of such securities and any shares of Common Stock that may be acquired upon exercise of the Private Placement Warrants were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of Fund V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Merger Warrants and the Private Placement Warrants held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":20175000,"derivative":{"exercise_price":0.2311,"expiration_date":"2026-07-09","underlying":"Common Stock","underlying_shares":20175000},"source":{"system":"sec-edgar","filing":"0001193805-24-000909","document":"e663773_4-biomx.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000909/e663773_4-biomx.xml","form_type":"4"}},{"id":1456465,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}}],"security":"Warrants","published_at":"2024-07-11T22:47:07.000Z","date":"2024-07-09","kind":"grant","planned":false,"acquired":true,"shares":20175000,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund V, L.P."},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"On March 15, 2024, each Fund purchased 40,350 shares of Series X Preferred Stock and warrants to purchase 20,175,000 shares of Common Stock in a private placement at a combined purchase price of $231.10 per share of Series X Preferred Stock and warrant to purchase one-half of one share of Common Stock (subject to adjustment as provided in the warrants) (the \"Private Placement Warrants\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"On March 15, 2024, each Fund purchased 40,350 shares of Series X Preferred Stock and warrants to purchase 20,175,000 shares of Common Stock in a private placement at a combined purchase price of $231.10 per share of Series X Preferred Stock and warrant to purchase one-half of one share of Common Stock (subject to adjustment as provided in the warrants) (the \"Private Placement Warrants\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The Private Placement Warrants were originally issued on March 15, 2024, but were not exercisable unless and until requisite approval of the Issuer's stockholder had been obtained. Such approval was obtained on July 9, 2024, whereupon the Merger Warrants became exercisable in accordance with their terms. The acquisition or deemed acquisition of such securities and any shares of Common Stock that may be acquired upon exercise of the Private Placement Warrants were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of Fund V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Merger Warrants and the Private Placement Warrants held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":20175000,"derivative":{"exercise_price":0.2311,"expiration_date":"2026-07-09","underlying":"Common Stock","underlying_shares":20175000},"source":{"system":"sec-edgar","filing":"0001193805-24-000909","document":"e663773_4-biomx.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000909/e663773_4-biomx.xml","form_type":"4"}},{"id":1456464,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}}],"security":"Warrants","published_at":"2024-07-11T22:47:07.000Z","date":"2024-07-09","kind":"grant","planned":false,"acquired":true,"shares":722175,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund II, L.P."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each of Deerfield Private Design Fund V, L.P. (\"Fund V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and, together with Fund V, the \"Funds\") acquired warrants to purchase 722,175 shares of Common Stock (the \"Merger Warrants\") pursuant to the Agreement and Plan of Merger, dated as of March 6, 2024 (the \"Merger Agreement\"), among the Issuer, BTX Merger Sub I, Inc., BTX Merger Sub II, LLC and Adaptive Phage Therapeutics, Inc. (\"APT\"). As a result of the transactions contemplated by the Merger Agreement (the \"Merger\"), 9,425,223 shares of Series B Preferred Stock and 16,972,145 shares of Series B-1 Preferred Stock of APT held by each of the Funds immediately prior to the Merger were converted into (i) 3,055,049 shares of Common Stock, (ii) 13,490 shares of Series X Non-Voting Convertible Preferred Stock (\"Series X Preferred Stock\") of the Issuer and (iii) the Merger Warrants."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each of Deerfield Private Design Fund V, L.P. (\"Fund V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and, together with Fund V, the \"Funds\") acquired warrants to purchase 722,175 shares of Common Stock (the \"Merger Warrants\") pursuant to the Agreement and Plan of Merger, dated as of March 6, 2024 (the \"Merger Agreement\"), among the Issuer, BTX Merger Sub I, Inc., BTX Merger Sub II, LLC and Adaptive Phage Therapeutics, Inc. (\"APT\"). As a result of the transactions contemplated by the Merger Agreement (the \"Merger\"), 9,425,223 shares of Series B Preferred Stock and 16,972,145 shares of Series B-1 Preferred Stock of APT held by each of the Funds immediately prior to the Merger were converted into (i) 3,055,049 shares of Common Stock, (ii) 13,490 shares of Series X Non-Voting Convertible Preferred Stock (\"Series X Preferred Stock\") of the Issuer and (iii) the Merger Warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Merger Warrants were originally issued on March 15, 2024, but were not exercisable unless and until requisite approval of the Issuer's stockholder had been obtained. Such approval was obtained on July 9, 2024, whereupon the Merger Warrants became exercisable in accordance with their terms. The acquisition or deemed acquisition of such securities and any shares of Common Stock that may be acquired upon exercise of the Merger Warrants were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of Fund V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Merger Warrants and the Private Placement Warrants held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":722175,"derivative":{"exercise_price":5,"expiration_date":"2027-01-28","underlying":"Common Stock","underlying_shares":722175},"source":{"system":"sec-edgar","filing":"0001193805-24-000909","document":"e663773_4-biomx.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000909/e663773_4-biomx.xml","form_type":"4"}},{"id":1456463,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}}],"security":"Warrants","published_at":"2024-07-11T22:47:07.000Z","date":"2024-07-09","kind":"grant","planned":false,"acquired":true,"shares":722175,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund V, L.P."},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Each of Deerfield Private Design Fund V, L.P. (\"Fund V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and, together with Fund V, the \"Funds\") acquired warrants to purchase 722,175 shares of Common Stock (the \"Merger Warrants\") pursuant to the Agreement and Plan of Merger, dated as of March 6, 2024 (the \"Merger Agreement\"), among the Issuer, BTX Merger Sub I, Inc., BTX Merger Sub II, LLC and Adaptive Phage Therapeutics, Inc. (\"APT\"). As a result of the transactions contemplated by the Merger Agreement (the \"Merger\"), 9,425,223 shares of Series B Preferred Stock and 16,972,145 shares of Series B-1 Preferred Stock of APT held by each of the Funds immediately prior to the Merger were converted into (i) 3,055,049 shares of Common Stock, (ii) 13,490 shares of Series X Non-Voting Convertible Preferred Stock (\"Series X Preferred Stock\") of the Issuer and (iii) the Merger Warrants."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each of Deerfield Private Design Fund V, L.P. (\"Fund V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and, together with Fund V, the \"Funds\") acquired warrants to purchase 722,175 shares of Common Stock (the \"Merger Warrants\") pursuant to the Agreement and Plan of Merger, dated as of March 6, 2024 (the \"Merger Agreement\"), among the Issuer, BTX Merger Sub I, Inc., BTX Merger Sub II, LLC and Adaptive Phage Therapeutics, Inc. (\"APT\"). As a result of the transactions contemplated by the Merger Agreement (the \"Merger\"), 9,425,223 shares of Series B Preferred Stock and 16,972,145 shares of Series B-1 Preferred Stock of APT held by each of the Funds immediately prior to the Merger were converted into (i) 3,055,049 shares of Common Stock, (ii) 13,490 shares of Series X Non-Voting Convertible Preferred Stock (\"Series X Preferred Stock\") of the Issuer and (iii) the Merger Warrants."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The Merger Warrants were originally issued on March 15, 2024, but were not exercisable unless and until requisite approval of the Issuer's stockholder had been obtained. Such approval was obtained on July 9, 2024, whereupon the Merger Warrants became exercisable in accordance with their terms. The acquisition or deemed acquisition of such securities and any shares of Common Stock that may be acquired upon exercise of the Merger Warrants were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of Fund V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Merger Warrants and the Private Placement Warrants held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":722175,"derivative":{"exercise_price":5,"expiration_date":"2027-01-28","underlying":"Common Stock","underlying_shares":722175},"source":{"system":"sec-edgar","filing":"0001193805-24-000909","document":"e663773_4-biomx.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000909/e663773_4-biomx.xml","form_type":"4"}},{"id":1570544,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}}],"security":"Series X Non-Voting Convertible Preferred Stock","published_at":"2024-03-20T01:39:16.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":40350,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Effective as of 5:00 p.m. on the 4th business day after the date that the Issuer's stockholders approve the conversion of the Series X Preferred Stock into shares of Common Stock in accordance with the listing rules of the NYSE American (the \"Stockholder Approval\"), each share of Series X Preferred Stock will become convertible (either automatically or at the election of the holder, and in either case, subject to a beneficial ownership limitation) into 1,000 shares of Common Stock (subject to adjustment) in accordance with the certificate of designation governing the Series X Preferred Stock (the \"Certificate of Designation\"). If the Stockholder Approval is not obtained by 5:00 p.m. on the date that is 5 months after the initial issuance of the Series X Preferred Stock (or such earlier time as a stockholder meeting is held and the Stockholder Approval is not obtained), the Series X Preferred Stock will become convertible into cash in accordance with the Certificate of Designation."},{"field":"kind","element":"transactionCoding","label":"F6","text":"On March 15, 2024, each Fund purchased 40,350 shares (the \"PIPE Preferred Shares\") of Series X Preferred Stock and warrants to purchase 20,175,000 Common Stock in a private placement at a combined purchase price of $231.10 per share of Series X Preferred Stock and warrant to purchase one-half of one share of Common Stock (subject to adjustment as provided in the warrants) (the \"Private Placement Warrants\"). The Private Placement Warrants are not currently exercisable and will not become exercisable unless and until requisite approval of the Issuer's stockholders is obtained. Accordingly, the Private Placement Warrants are not reported herein. The acquisition or deemed acquisition of such securities and any shares of Common Stock that may be acquired upon conversion or exercise of the PIPE Preferred Shares or the Private Placement Warrants were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On March 15, 2024, each Fund purchased 40,350 shares (the \"PIPE Preferred Shares\") of Series X Preferred Stock and warrants to purchase 20,175,000 Common Stock in a private placement at a combined purchase price of $231.10 per share of Series X Preferred Stock and warrant to purchase one-half of one share of Common Stock (subject to adjustment as provided in the warrants) (the \"Private Placement Warrants\"). The Private Placement Warrants are not currently exercisable and will not become exercisable unless and until requisite approval of the Issuer's stockholders is obtained. Accordingly, the Private Placement Warrants are not reported herein. The acquisition or deemed acquisition of such securities and any shares of Common Stock that may be acquired upon conversion or exercise of the PIPE Preferred Shares or the Private Placement Warrants were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Effective as of 5:00 p.m. on the 4th business day after the date that the Issuer's stockholders approve the conversion of the Series X Preferred Stock into shares of Common Stock in accordance with the listing rules of the NYSE American (the \"Stockholder Approval\"), each share of Series X Preferred Stock will become convertible (either automatically or at the election of the holder, and in either case, subject to a beneficial ownership limitation) into 1,000 shares of Common Stock (subject to adjustment) in accordance with the certificate of designation governing the Series X Preferred Stock (the \"Certificate of Designation\"). If the Stockholder Approval is not obtained by 5:00 p.m. on the date that is 5 months after the initial issuance of the Series X Preferred Stock (or such earlier time as a stockholder meeting is held and the Stockholder Approval is not obtained), the Series X Preferred Stock will become convertible into cash in accordance with the Certificate of Designation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Effective as of 5:00 p.m. on the 4th business day after the date that the Issuer's stockholders approve the conversion of the Series X Preferred Stock into shares of Common Stock in accordance with the listing rules of the NYSE American (the \"Stockholder Approval\"), each share of Series X Preferred Stock will become convertible (either automatically or at the election of the holder, and in either case, subject to a beneficial ownership limitation) into 1,000 shares of Common Stock (subject to adjustment) in accordance with the certificate of designation governing the Series X Preferred Stock (the \"Certificate of Designation\"). If the Stockholder Approval is not obtained by 5:00 p.m. on the date that is 5 months after the initial issuance of the Series X Preferred Stock (or such earlier time as a stockholder meeting is held and the Stockholder Approval is not obtained), the Series X Preferred Stock will become convertible into cash in accordance with the Certificate of Designation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of Fund V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":53840,"derivative":{"underlying":"Common Stock","underlying_shares":40350000},"source":{"system":"sec-edgar","filing":"0001193805-24-000414","document":"e619387_4-biomx.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000414/e619387_4-biomx.xml","form_type":"4"}},{"id":1570543,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}}],"security":"Series X Non-Voting Convertible Preferred Stock","published_at":"2024-03-20T01:39:16.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":40350,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Effective as of 5:00 p.m. on the 4th business day after the date that the Issuer's stockholders approve the conversion of the Series X Preferred Stock into shares of Common Stock in accordance with the listing rules of the NYSE American (the \"Stockholder Approval\"), each share of Series X Preferred Stock will become convertible (either automatically or at the election of the holder, and in either case, subject to a beneficial ownership limitation) into 1,000 shares of Common Stock (subject to adjustment) in accordance with the certificate of designation governing the Series X Preferred Stock (the \"Certificate of Designation\"). If the Stockholder Approval is not obtained by 5:00 p.m. on the date that is 5 months after the initial issuance of the Series X Preferred Stock (or such earlier time as a stockholder meeting is held and the Stockholder Approval is not obtained), the Series X Preferred Stock will become convertible into cash in accordance with the Certificate of Designation."},{"field":"kind","element":"transactionCoding","label":"F6","text":"On March 15, 2024, each Fund purchased 40,350 shares (the \"PIPE Preferred Shares\") of Series X Preferred Stock and warrants to purchase 20,175,000 Common Stock in a private placement at a combined purchase price of $231.10 per share of Series X Preferred Stock and warrant to purchase one-half of one share of Common Stock (subject to adjustment as provided in the warrants) (the \"Private Placement Warrants\"). The Private Placement Warrants are not currently exercisable and will not become exercisable unless and until requisite approval of the Issuer's stockholders is obtained. Accordingly, the Private Placement Warrants are not reported herein. The acquisition or deemed acquisition of such securities and any shares of Common Stock that may be acquired upon conversion or exercise of the PIPE Preferred Shares or the Private Placement Warrants were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"On March 15, 2024, each Fund purchased 40,350 shares (the \"PIPE Preferred Shares\") of Series X Preferred Stock and warrants to purchase 20,175,000 Common Stock in a private placement at a combined purchase price of $231.10 per share of Series X Preferred Stock and warrant to purchase one-half of one share of Common Stock (subject to adjustment as provided in the warrants) (the \"Private Placement Warrants\"). The Private Placement Warrants are not currently exercisable and will not become exercisable unless and until requisite approval of the Issuer's stockholders is obtained. Accordingly, the Private Placement Warrants are not reported herein. The acquisition or deemed acquisition of such securities and any shares of Common Stock that may be acquired upon conversion or exercise of the PIPE Preferred Shares or the Private Placement Warrants were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Effective as of 5:00 p.m. on the 4th business day after the date that the Issuer's stockholders approve the conversion of the Series X Preferred Stock into shares of Common Stock in accordance with the listing rules of the NYSE American (the \"Stockholder Approval\"), each share of Series X Preferred Stock will become convertible (either automatically or at the election of the holder, and in either case, subject to a beneficial ownership limitation) into 1,000 shares of Common Stock (subject to adjustment) in accordance with the certificate of designation governing the Series X Preferred Stock (the \"Certificate of Designation\"). If the Stockholder Approval is not obtained by 5:00 p.m. on the date that is 5 months after the initial issuance of the Series X Preferred Stock (or such earlier time as a stockholder meeting is held and the Stockholder Approval is not obtained), the Series X Preferred Stock will become convertible into cash in accordance with the Certificate of Designation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Effective as of 5:00 p.m. on the 4th business day after the date that the Issuer's stockholders approve the conversion of the Series X Preferred Stock into shares of Common Stock in accordance with the listing rules of the NYSE American (the \"Stockholder Approval\"), each share of Series X Preferred Stock will become convertible (either automatically or at the election of the holder, and in either case, subject to a beneficial ownership limitation) into 1,000 shares of Common Stock (subject to adjustment) in accordance with the certificate of designation governing the Series X Preferred Stock (the \"Certificate of Designation\"). If the Stockholder Approval is not obtained by 5:00 p.m. on the date that is 5 months after the initial issuance of the Series X Preferred Stock (or such earlier time as a stockholder meeting is held and the Stockholder Approval is not obtained), the Series X Preferred Stock will become convertible into cash in accordance with the Certificate of Designation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of Fund V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":53840,"derivative":{"underlying":"Common Stock","underlying_shares":40350000},"source":{"system":"sec-edgar","filing":"0001193805-24-000414","document":"e619387_4-biomx.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000414/e619387_4-biomx.xml","form_type":"4"}},{"id":1570542,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}}],"security":"Series X Non-Voting Convertible Preferred Stock","published_at":"2024-03-20T01:39:16.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":13490,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund II, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Effective as of 5:00 p.m. on the 4th business day after the date that the Issuer's stockholders approve the conversion of the Series X Preferred Stock into shares of Common Stock in accordance with the listing rules of the NYSE American (the \"Stockholder Approval\"), each share of Series X Preferred Stock will become convertible (either automatically or at the election of the holder, and in either case, subject to a beneficial ownership limitation) into 1,000 shares of Common Stock (subject to adjustment) in accordance with the certificate of designation governing the Series X Preferred Stock (the \"Certificate of Designation\"). If the Stockholder Approval is not obtained by 5:00 p.m. on the date that is 5 months after the initial issuance of the Series X Preferred Stock (or such earlier time as a stockholder meeting is held and the Stockholder Approval is not obtained), the Series X Preferred Stock will become convertible into cash in accordance with the Certificate of Designation."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of Common Stock and Merger Preferred Shares (as defined below) reported herein were acquired by Deerfield Private Design Fund V, L.P. (\"Fund V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and, together with Fund V, the \"Funds\") pursuant to the Agreement and Plan of Merger, dated as of March 6, 2024 (the \"Merger Agreement\"), among the Issuer, BTX Merger Sub I, Inc., BTX Merger Sub II, LLC and Adaptive Phage Therapeutics, Inc. (\"APT\"). The acquisition or deemed acquisition of such securities and the Merger Warrants (as defined below) and any shares of Common Stock that may be acquired upon conversion or exercise of the Merger Preferred Shares or the Merger Warrants were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"As a result of the transactions contemplated by the Merger Agreement (the \"Merger\"), 16,972,145 shares of Series B-1 Preferred Stock of APT held by each of the Funds immediately prior to the Merger were converted into (i) 3,055,049 shares of Common Stock, (ii) 13,490 shares of Series X Non-Voting Convertible Preferred Stock (\"Series X Preferred Stock\") of the Issuer (the \"Merger Preferred Shares\") and (iii) warrants to purchase 722,175 shares of Common Stock (the \"Merger Warrants\"). The Merger Warrants are not currently exercisable and will not become exercisable unless and until requisite approval of the Issuer's stockholder is obtained. Accordingly, the Merger Warrants are not reported herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Effective as of 5:00 p.m. on the 4th business day after the date that the Issuer's stockholders approve the conversion of the Series X Preferred Stock into shares of Common Stock in accordance with the listing rules of the NYSE American (the \"Stockholder Approval\"), each share of Series X Preferred Stock will become convertible (either automatically or at the election of the holder, and in either case, subject to a beneficial ownership limitation) into 1,000 shares of Common Stock (subject to adjustment) in accordance with the certificate of designation governing the Series X Preferred Stock (the \"Certificate of Designation\"). If the Stockholder Approval is not obtained by 5:00 p.m. on the date that is 5 months after the initial issuance of the Series X Preferred Stock (or such earlier time as a stockholder meeting is held and the Stockholder Approval is not obtained), the Series X Preferred Stock will become convertible into cash in accordance with the Certificate of Designation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Effective as of 5:00 p.m. on the 4th business day after the date that the Issuer's stockholders approve the conversion of the Series X Preferred Stock into shares of Common Stock in accordance with the listing rules of the NYSE American (the \"Stockholder Approval\"), each share of Series X Preferred Stock will become convertible (either automatically or at the election of the holder, and in either case, subject to a beneficial ownership limitation) into 1,000 shares of Common Stock (subject to adjustment) in accordance with the certificate of designation governing the Series X Preferred Stock (the \"Certificate of Designation\"). If the Stockholder Approval is not obtained by 5:00 p.m. on the date that is 5 months after the initial issuance of the Series X Preferred Stock (or such earlier time as a stockholder meeting is held and the Stockholder Approval is not obtained), the Series X Preferred Stock will become convertible into cash in accordance with the Certificate of Designation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of Fund V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":13490,"derivative":{"underlying":"Common Stock","underlying_shares":13490000},"source":{"system":"sec-edgar","filing":"0001193805-24-000414","document":"e619387_4-biomx.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000414/e619387_4-biomx.xml","form_type":"4"}},{"id":1570541,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}}],"security":"Series X Non-Voting Convertible Preferred Stock","published_at":"2024-03-20T01:39:16.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":13490,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund V, L.P."},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F5","text":"Effective as of 5:00 p.m. on the 4th business day after the date that the Issuer's stockholders approve the conversion of the Series X Preferred Stock into shares of Common Stock in accordance with the listing rules of the NYSE American (the \"Stockholder Approval\"), each share of Series X Preferred Stock will become convertible (either automatically or at the election of the holder, and in either case, subject to a beneficial ownership limitation) into 1,000 shares of Common Stock (subject to adjustment) in accordance with the certificate of designation governing the Series X Preferred Stock (the \"Certificate of Designation\"). If the Stockholder Approval is not obtained by 5:00 p.m. on the date that is 5 months after the initial issuance of the Series X Preferred Stock (or such earlier time as a stockholder meeting is held and the Stockholder Approval is not obtained), the Series X Preferred Stock will become convertible into cash in accordance with the Certificate of Designation."},{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of Common Stock and Merger Preferred Shares (as defined below) reported herein were acquired by Deerfield Private Design Fund V, L.P. (\"Fund V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and, together with Fund V, the \"Funds\") pursuant to the Agreement and Plan of Merger, dated as of March 6, 2024 (the \"Merger Agreement\"), among the Issuer, BTX Merger Sub I, Inc., BTX Merger Sub II, LLC and Adaptive Phage Therapeutics, Inc. (\"APT\"). The acquisition or deemed acquisition of such securities and the Merger Warrants (as defined below) and any shares of Common Stock that may be acquired upon conversion or exercise of the Merger Preferred Shares or the Merger Warrants were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"As a result of the transactions contemplated by the Merger Agreement (the \"Merger\"), 16,972,145 shares of Series B-1 Preferred Stock of APT held by each of the Funds immediately prior to the Merger were converted into (i) 3,055,049 shares of Common Stock, (ii) 13,490 shares of Series X Non-Voting Convertible Preferred Stock (\"Series X Preferred Stock\") of the Issuer (the \"Merger Preferred Shares\") and (iii) warrants to purchase 722,175 shares of Common Stock (the \"Merger Warrants\"). The Merger Warrants are not currently exercisable and will not become exercisable unless and until requisite approval of the Issuer's stockholder is obtained. Accordingly, the Merger Warrants are not reported herein."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Effective as of 5:00 p.m. on the 4th business day after the date that the Issuer's stockholders approve the conversion of the Series X Preferred Stock into shares of Common Stock in accordance with the listing rules of the NYSE American (the \"Stockholder Approval\"), each share of Series X Preferred Stock will become convertible (either automatically or at the election of the holder, and in either case, subject to a beneficial ownership limitation) into 1,000 shares of Common Stock (subject to adjustment) in accordance with the certificate of designation governing the Series X Preferred Stock (the \"Certificate of Designation\"). If the Stockholder Approval is not obtained by 5:00 p.m. on the date that is 5 months after the initial issuance of the Series X Preferred Stock (or such earlier time as a stockholder meeting is held and the Stockholder Approval is not obtained), the Series X Preferred Stock will become convertible into cash in accordance with the Certificate of Designation."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Effective as of 5:00 p.m. on the 4th business day after the date that the Issuer's stockholders approve the conversion of the Series X Preferred Stock into shares of Common Stock in accordance with the listing rules of the NYSE American (the \"Stockholder Approval\"), each share of Series X Preferred Stock will become convertible (either automatically or at the election of the holder, and in either case, subject to a beneficial ownership limitation) into 1,000 shares of Common Stock (subject to adjustment) in accordance with the certificate of designation governing the Series X Preferred Stock (the \"Certificate of Designation\"). If the Stockholder Approval is not obtained by 5:00 p.m. on the date that is 5 months after the initial issuance of the Series X Preferred Stock (or such earlier time as a stockholder meeting is held and the Stockholder Approval is not obtained), the Series X Preferred Stock will become convertible into cash in accordance with the Certificate of Designation."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of Fund V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":13490,"derivative":{"underlying":"Common Stock","underlying_shares":13490000},"source":{"system":"sec-edgar","filing":"0001193805-24-000414","document":"e619387_4-biomx.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000414/e619387_4-biomx.xml","form_type":"4"}},{"id":1570540,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}}],"security":"Common Stock","published_at":"2024-03-20T01:39:16.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":3055049,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund II, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of Common Stock and Merger Preferred Shares (as defined below) reported herein were acquired by Deerfield Private Design Fund V, L.P. (\"Fund V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and, together with Fund V, the \"Funds\") pursuant to the Agreement and Plan of Merger, dated as of March 6, 2024 (the \"Merger Agreement\"), among the Issuer, BTX Merger Sub I, Inc., BTX Merger Sub II, LLC and Adaptive Phage Therapeutics, Inc. (\"APT\"). The acquisition or deemed acquisition of such securities and the Merger Warrants (as defined below) and any shares of Common Stock that may be acquired upon conversion or exercise of the Merger Preferred Shares or the Merger Warrants were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"As a result of the transactions contemplated by the Merger Agreement (the \"Merger\"), 16,972,145 shares of Series B-1 Preferred Stock of APT held by each of the Funds immediately prior to the Merger were converted into (i) 3,055,049 shares of Common Stock, (ii) 13,490 shares of Series X Non-Voting Convertible Preferred Stock (\"Series X Preferred Stock\") of the Issuer (the \"Merger Preferred Shares\") and (iii) warrants to purchase 722,175 shares of Common Stock (the \"Merger Warrants\"). The Merger Warrants are not currently exercisable and will not become exercisable unless and until requisite approval of the Issuer's stockholder is obtained. Accordingly, the Merger Warrants are not reported herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of Fund V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":3055049,"source":{"system":"sec-edgar","filing":"0001193805-24-000414","document":"e619387_4-biomx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000414/e619387_4-biomx.xml","form_type":"4"}},{"id":1570539,"issuer":{"id":8384,"kind":"organization","name":"Tessera Defense & Homeland Security Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80584,"kind":"person","name":"Deerfield Mgmt V, L.P.","position":3,"cik":"0001876688","reported_name":"Deerfield Mgmt V, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80585,"kind":"person","name":"Deerfield Private Design Fund V, L.P.","position":5,"cik":"0001815437","reported_name":"Deerfield Private Design Fund V, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}},{"id":80586,"kind":"person","name":"Deerfield Healthcare Innovations Fund II, L.P.","position":6,"cik":"0001780064","reported_name":"Deerfield Healthcare Innovations Fund II, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Director by Deputization"}}],"security":"Common Stock","published_at":"2024-03-20T01:39:16.000Z","date":"2024-03-15","kind":"grant","planned":false,"acquired":true,"shares":3055049,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund V, L.P."},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The shares of Common Stock and Merger Preferred Shares (as defined below) reported herein were acquired by Deerfield Private Design Fund V, L.P. (\"Fund V\") and Deerfield Healthcare Innovations Fund II, L.P. (\"HIF II\" and, together with Fund V, the \"Funds\") pursuant to the Agreement and Plan of Merger, dated as of March 6, 2024 (the \"Merger Agreement\"), among the Issuer, BTX Merger Sub I, Inc., BTX Merger Sub II, LLC and Adaptive Phage Therapeutics, Inc. (\"APT\"). The acquisition or deemed acquisition of such securities and the Merger Warrants (as defined below) and any shares of Common Stock that may be acquired upon conversion or exercise of the Merger Preferred Shares or the Merger Warrants were exempted pursuant to Rule 16b-3 under the Securities Exchange Act of 1934, as amended."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"As a result of the transactions contemplated by the Merger Agreement (the \"Merger\"), 16,972,145 shares of Series B-1 Preferred Stock of APT held by each of the Funds immediately prior to the Merger were converted into (i) 3,055,049 shares of Common Stock, (ii) 13,490 shares of Series X Non-Voting Convertible Preferred Stock (\"Series X Preferred Stock\") of the Issuer (the \"Merger Preferred Shares\") and (iii) warrants to purchase 722,175 shares of Common Stock (the \"Merger Warrants\"). The Merger Warrants are not currently exercisable and will not become exercisable unless and until requisite approval of the Issuer's stockholder is obtained. Accordingly, the Merger Warrants are not reported herein."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt V, L.P. is the general partner of Fund V. Deerfield Mgmt HIF II, L.P. is the general partner of HIF II. Deerfield Management Company, L.P. is the investment manager of each Fund. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt V, L.P., Deerfield Mgmt HIF II, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":3055049,"source":{"system":"sec-edgar","filing":"0001193805-24-000414","document":"e619387_4-biomx.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000414/e619387_4-biomx.xml","form_type":"4"}},{"id":1639318,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2024-02-16T19:37:50.000Z","date":"2024-02-16","kind":"purchase","planned":false,"acquired":true,"shares":1430205,"price":8.74,"value":12499991.7,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":4207982,"source":{"system":"sec-edgar","filing":"0001193805-24-000245","document":"e619284_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000245/e619284_4-larimar.xml","form_type":"4"}},{"id":1639317,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2024-02-16T19:37:50.000Z","date":"2024-02-16","kind":"purchase","planned":false,"acquired":true,"shares":1430206,"price":8.74,"value":12500000.44,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund IV, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":6151406,"source":{"system":"sec-edgar","filing":"0001193805-24-000245","document":"e619284_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000245/e619284_4-larimar.xml","form_type":"4"}},{"id":1639316,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":2,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":3,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":4,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29899,"kind":"person","name":"Deerfield Mgmt IV, L.P.","position":5,"cik":"0001713467","reported_name":"Deerfield Mgmt IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":6,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":8,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29900,"kind":"person","name":"Deerfield Private Design Fund IV, L.P.","position":9,"cik":"0001680307","reported_name":"Deerfield Private Design Fund IV, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":10,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":true,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"* Director by Deputization"}}],"security":"Common Stock","published_at":"2024-02-16T19:37:50.000Z","date":"2024-02-16","kind":"purchase","planned":false,"acquired":true,"shares":1430206,"price":8.74,"value":12500000.44,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt IV, L.P. is the general partner of Deerfield Private Design Fund IV, L.P. (\"Fund IV\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (\"Deerfield HIF\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Management Company, L.P. is the investment manager of Deerfield Partners, L.P., Fund III, Fund IV and Deerfield HIF (collectively, the \"Funds\"). James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt III, L.P., Deerfield Mgmt IV, L.P., Deerfield Mgmt HIF, L.P., Deerfield Mgmt, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":6151389,"source":{"system":"sec-edgar","filing":"0001193805-24-000245","document":"e619284_4-larimar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380524000245/e619284_4-larimar.xml","form_type":"4"}},{"id":2074550,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-30","kind":"sale","acquired":false,"shares":15220,"price":0.27,"value":4109.4,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.26 to $0.28, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":284697,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2074549,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-30","kind":"sale","acquired":false,"shares":61826,"price":0.27,"value":16693.02,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.26 to $0.28, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1156308,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2074548,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-30","kind":"sale","acquired":false,"shares":61826,"price":0.27,"value":16693.02,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.26 to $0.28, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1156309,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2074547,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-29","kind":"sale","acquired":false,"shares":15538,"price":0.26,"value":4039.88,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.25 to $0.27, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":299917,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2074546,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-29","kind":"sale","acquired":false,"shares":63108,"price":0.26,"value":16408.08,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.25 to $0.27, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1218134,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2074545,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-29","kind":"sale","acquired":false,"shares":63107,"price":0.26,"value":16407.82,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.25 to $0.27, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1218135,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2074544,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-28","kind":"sale","acquired":false,"shares":6096,"price":0.25,"value":1524.0,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.25 to $0.26, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-3 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":315455,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2074543,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-28","kind":"sale","acquired":false,"shares":24757,"price":0.25,"value":6189.25,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.25 to $0.26, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-3 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1281242,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2074542,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-31T00:16:31.000Z","date":"2022-12-28","kind":"sale","acquired":false,"shares":24757,"price":0.25,"value":6189.25,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.25 to $0.26, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-3 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1281242,"source":{"system":"sec-edgar","filing":"0001193805-22-001817","document":"e618175_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001817/e618175_4-oncorus.xml","form_type":"4"}},{"id":2076301,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-27T23:33:56.000Z","date":"2022-12-27","kind":"sale","acquired":false,"shares":7136,"price":0.27,"value":1926.72,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.26 to $0.29, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":321551,"source":{"system":"sec-edgar","filing":"0001193805-22-001793","document":"e618164_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001793/e618164_4-oncorus.xml","form_type":"4"}},{"id":2076300,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-27T23:33:56.000Z","date":"2022-12-27","kind":"sale","acquired":false,"shares":28977,"price":0.27,"value":7823.79,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.26 to $0.29, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1305999,"source":{"system":"sec-edgar","filing":"0001193805-22-001793","document":"e618164_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001793/e618164_4-oncorus.xml","form_type":"4"}},{"id":2076299,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-27T23:33:56.000Z","date":"2022-12-27","kind":"sale","acquired":false,"shares":28977,"price":0.27,"value":7823.79,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.26 to $0.29, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1305999,"source":{"system":"sec-edgar","filing":"0001193805-22-001793","document":"e618164_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001793/e618164_4-oncorus.xml","form_type":"4"}},{"id":2076298,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-27T23:33:56.000Z","date":"2022-12-22","kind":"sale","acquired":false,"shares":909,"price":0.28,"value":254.52,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.28 to $0.29, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-2 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":328687,"source":{"system":"sec-edgar","filing":"0001193805-22-001793","document":"e618164_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001793/e618164_4-oncorus.xml","form_type":"4"}},{"id":2076297,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-27T23:33:56.000Z","date":"2022-12-22","kind":"sale","acquired":false,"shares":3693,"price":0.28,"value":1034.04,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.28 to $0.29, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-2 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1334976,"source":{"system":"sec-edgar","filing":"0001193805-22-001793","document":"e618164_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001793/e618164_4-oncorus.xml","form_type":"4"}},{"id":2076296,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-27T23:33:56.000Z","date":"2022-12-22","kind":"sale","acquired":false,"shares":3692,"price":0.28,"value":1033.76,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.28 to $0.29, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-2 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1334976,"source":{"system":"sec-edgar","filing":"0001193805-22-001793","document":"e618164_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001793/e618164_4-oncorus.xml","form_type":"4"}},{"id":2079078,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":1513,"price":0.3,"value":453.9,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.29 to $0.30, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":329596,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2079077,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":6143,"price":0.3,"value":1842.9,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.29 to $0.30, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1338669,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2079076,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-21","kind":"sale","acquired":false,"shares":6144,"price":0.3,"value":1843.2,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.29 to $0.30, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1338668,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2079075,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-20","kind":"sale","acquired":false,"shares":1616,"price":0.31,"value":500.96,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.30 to $0.32, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":331109,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2079074,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-20","kind":"sale","acquired":false,"shares":6562,"price":0.31,"value":2034.22,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.30 to $0.32, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1344812,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2079073,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-20","kind":"sale","acquired":false,"shares":6562,"price":0.31,"value":2034.22,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.30 to $0.32, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1344812,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2079072,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-19","kind":"sale","acquired":false,"shares":10930,"price":0.29,"value":3169.7,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.28 to $0.30, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-3 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":332725,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2079071,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-19","kind":"sale","acquired":false,"shares":44394,"price":0.29,"value":12874.26,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.28 to $0.30, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-3 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1351374,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2079070,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-22T00:09:24.000Z","date":"2022-12-19","kind":"sale","acquired":false,"shares":44394,"price":0.29,"value":12874.26,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.28 to $0.30, inclusive. The reporting persons undertake to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes 1-3 of this Form 4."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1351374,"source":{"system":"sec-edgar","filing":"0001193805-22-001764","document":"e618154_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001764/e618154_4-oncorus.xml","form_type":"4"}},{"id":2085584,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-15T23:50:29.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":339,"price":0.39,"value":132.21,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.39 to $0.41, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":343655,"source":{"system":"sec-edgar","filing":"0001193805-22-001734","document":"e618131_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001734/e618131_4-oncorus.xml","form_type":"4"}},{"id":2085583,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-15T23:50:29.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":1375,"price":0.39,"value":536.25,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.39 to $0.41, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1395768,"source":{"system":"sec-edgar","filing":"0001193805-22-001734","document":"e618131_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001734/e618131_4-oncorus.xml","form_type":"4"}},{"id":2085582,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-15T23:50:29.000Z","date":"2022-12-15","kind":"sale","acquired":false,"shares":1375,"price":0.39,"value":536.25,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.39 to $0.41, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1395768,"source":{"system":"sec-edgar","filing":"0001193805-22-001734","document":"e618131_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001734/e618131_4-oncorus.xml","form_type":"4"}},{"id":2085581,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-15T23:50:29.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":943,"price":0.38,"value":358.34,"ownership":{"direct":false,"nature":"Through Deerfield Partners, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.37 to $0.38, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":343994,"source":{"system":"sec-edgar","filing":"0001193805-22-001734","document":"e618131_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001734/e618131_4-oncorus.xml","form_type":"4"}},{"id":2085580,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-15T23:50:29.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":3829,"price":0.38,"value":1455.02,"ownership":{"direct":false,"nature":"Through Deerfield Private Design Fund III, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.37 to $0.38, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1397143,"source":{"system":"sec-edgar","filing":"0001193805-22-001734","document":"e618131_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001734/e618131_4-oncorus.xml","form_type":"4"}},{"id":2085579,"issuer":{"id":112213,"kind":"organization","name":"Oncorus, Inc.","symbol":"ONCR"},"owners":[{"id":29893,"kind":"person","name":"Flynn James E","position":1,"cik":"0001352546","reported_name":"Flynn James E","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29895,"kind":"person","name":"Deerfield Mgmt HIF, L.P.","position":2,"cik":"0001665736","reported_name":"Deerfield Mgmt HIF, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29894,"kind":"person","name":"DEERFIELD MANAGEMENT COMPANY, L.P.","position":3,"cik":"0001009258","reported_name":"DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C)","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29896,"kind":"person","name":"Deerfield Healthcare Innovations Fund, L.P.","position":4,"cik":"0001646981","reported_name":"Deerfield Healthcare Innovations Fund, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29898,"kind":"person","name":"Deerfield Mgmt L.P.","position":5,"cik":"0001010823","reported_name":"Deerfield Mgmt L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39427,"kind":"organization","name":"Deerfield Mgmt III, L.P.","position":6,"cik":"0001610540","reported_name":"Deerfield Mgmt III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":39428,"kind":"organization","name":"Deerfield Private Design Fund III, L.P.","position":7,"cik":"0001603333","reported_name":"Deerfield Private Design Fund III, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}},{"id":29897,"kind":"person","name":"DEERFIELD PARTNERS, L.P.","position":8,"cik":"0001301041","reported_name":"DEERFIELD PARTNERS, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":true,"other_text":"*Possible Member of 10% Group"}}],"security":"Common Stock","published_at":"2022-12-15T23:50:29.000Z","date":"2022-12-14","kind":"sale","acquired":false,"shares":3828,"price":0.38,"value":1454.64,"ownership":{"direct":false,"nature":"Through Deerfield Healthcare Innovations Fund, L.P."},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 represents a weighted average price. The shares were sold in multiple transactions at prices ranging from $0.37 to $0.38, inclusive."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F4","text":"This Form 4 is being filed by the undersigned as well as the entities listed on the Joint Filer Information Statement attached as an exhibit hereto (the \"Reporting Persons\"). Deerfield Mgmt III, L.P. is the general partner of Deerfield Private Design Fund III, L.P. (\"Fund III\"). Deerfield Mgmt, L.P. is the general partner of Deerfield Partners, L.P. (\"Deerfield Partners\"). Deerfield Mgmt HIF, L.P. is the general partner of Deerfield Healthcare Innovations Fund, L.P. (collectively with Fund III and Deerfield Partners, the \"Funds\"). Deerfield Management Company, L.P. is the investment manager of the Funds. James E. Flynn is the sole member of the general partner of each of Deerfield Mgmt, L.P., Deerfield Mgmt III, L.P., Deerfield Mgmt HIF, L.P. and Deerfield Management Company, L.P."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F5","text":"In accordance with Instruction 4 (b)(iv) to Form 4, the entire amount of the Issuer's securities held by the Funds is reported herein. For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its indirect pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise."}],"balance_after":1397143,"source":{"system":"sec-edgar","filing":"0001193805-22-001734","document":"e618131_4-oncorus.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1009258/000119380522001734/e618131_4-oncorus.xml","form_type":"4"}}],"next_cursor":"2022-12-15T23:50:29.000000Z,2085579"}